About Tekmira

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) is a leading RNA interference (RNAi) therapeutics company. With more than 14 years of industry experience, Tekmira is a global leader in the RNAi field. We are developing novel drugs in areas where there is a significant unmet medical need and commercial opportunity. We also license our leading lipid nanoparticle (LNP) delivery technology to partners around the world.


Read More




Tekmira has a diverse pipeline of products in development to treat serious human diseases like cancer and viral infections such as Hepatitis B and Ebola.


View Our Pipeline Products


Merger Update

Please click here for updates on our strategic transaction and proxy materials.